Literature DB >> 16868688

The significance of p53 and bcl-2 overexpression and other prognostic factors in transitional cell carcinoma of the bladder.

Stavros Touloupidis1, Georgios Fatles, Christos Kalaitzis, Alexandra Giatromanolaki, Eythimyos Sivridis, Konstantinos Simopoulos, Vassilios Rombis.   

Abstract

The aim of this study was to investigate the expression of bcl-2 and p53 oncoproteins in a series of transitional cell bladder carcinomas and its relation to traditional prognostic indicators and patients' survival. Specimens from 59 patients who underwent transurethral resection from March 1992 to February 1997 were included in this study. Tumors were graded based on WHO grades 1-3 and staged according to the 1997 TNM classification. Three patients lost to follow-up were excluded from the analysis. We could not establish a statistically significant relation between bcl-2 and p53 and other parameters such as sex, age, stage and grade. Tumor grade and stage were the most important factors for predicting tumor recurrence and aggressiveness. Only sex seems to significantly affect the statistics of the risk of death (p<0.05). Women had quadruple risk of death compared to men.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16868688     DOI: 10.1007/s11255-005-4763-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  17 in total

Review 1.  Genetic studies and molecular markers of bladder cancer.

Authors:  C Cordon-Cardo; J Sheinfeld; G Dalbagni
Journal:  Semin Surg Oncol       Date:  1997 Sep-Oct

2.  The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma.

Authors:  T T Wu; J H Chen; Y H Lee; J K Huang
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

3.  Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.

Authors:  M G Friedrich; A Erbersdobler; H Schwaibold; S Conrad; E Huland; H Huland
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

4.  Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2.

Authors:  R T Vollmer; P A Humphrey; P E Swanson; M R Wick; M L Hudson
Journal:  Cancer       Date:  1998-02-15       Impact factor: 6.860

5.  The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.

Authors:  L Nakopoulou; C Vourlakou; A Zervas; A Tzonou; H Gakiopoulou; M A Dimopoulos
Journal:  Hum Pathol       Date:  1998-02       Impact factor: 3.466

6.  Expression of bcl-2 and bcl-X in bladder cancer.

Authors:  E J Kirsh; D A Baunoch; W M Stadler
Journal:  J Urol       Date:  1998-04       Impact factor: 7.450

7.  Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group.

Authors:  T Liukkonen; P Rajala; M Raitanen; E Rintala; E Kaasinen; P Lipponen
Journal:  Eur Urol       Date:  1999-11       Impact factor: 20.096

8.  Immunohistochemical determination of p53 overexpression. An easy and readily available method to identify progression in superficial bladder cancer?

Authors:  F C Burkhard; R Markwalder; G N Thalmann; U E Studer
Journal:  Urol Res       Date:  1997

9.  Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group.

Authors:  T J Liukkonen; P K Lipponen; M Helle; K E Jauhiainen
Journal:  Urol Res       Date:  1997

10.  Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder.

Authors:  B Li; H Kanamaru; S Noriki; T Yamaguchi; M Fukuda; K Okada
Journal:  Urol Res       Date:  1998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.